RA Capital Nexus Fund III, L.P.
Insider CIK 1883840 · PBLS Director · CLYM Director, 10% owner · SGP Director · ARTV Director · MLYS Director, 10% owner · SEPN Director · FRNM Director · BCAX Director · SION Director · EVMN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 725,443 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 4,777,415 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 725,443 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 4,777,415 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-23 | 2026-07-23 | 59,880 | $9.96 | $596.4K | 17,242,483 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-22 | 2026-07-22 | 47,250 | $29.77 | $1.41M | 26,529,686 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-22 | 2026-07-23 | 84,124 | $9.93 | $835.4K | 17,182,603 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 37,723 | $30.00 | $1.13M | 26,482,436 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 6,504 | $29.17 | $189.7K | 26,444,713 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 21,696 | $27.96 | $606.6K | 26,438,209 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-21 | 2026-07-23 | 120,582 | $9.55 | $1.15M | 17,098,479 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-20 | 2026-07-22 | 98,433 | $27.13 | $2.67M | 26,383,526 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-20 | 2026-07-22 | 32,987 | $27.72 | $914.4K | 26,416,513 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 336,965 | $10.00 | $3.37M | 1,245,068 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 4,918,411 | $10.00 | $49.18M | 12,230,122 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 367,427 | — | $0 | 367,427 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 908,103 | — | $0 | 908,103 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 553,703 | — | $0 | 553,703 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 970,950 | — | $0 | 970,950 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 6,561,711 | — | $0 | 7,311,711 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-17 | 2026-07-20 | 7,882 | $8.95 | $70.5K | 16,977,927 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-16 | 2026-07-20 | 152,472 | $8.93 | $1.36M | 16,970,045 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-14 | 6,552 | $8.94 | $58.6K | 16,817,573 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-23 | 6,522 | $8.94 | $58.3K | 16,817,543 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-10 | 2026-07-14 | 15,102 | $8.97 | $135.5K | 16,811,021 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-29 | 2026-07-01 | 70,284 | — | $0 | 70,284 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2026-06-26 | 2026-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-26 | 2026-06-29 | 1,876 | $8.98 | $16.8K | 16,795,919 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-25 | 2026-06-29 | 31,000 | $8.88 | $275.3K | 16,794,043 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-16 | 2026-06-16 | 124,893 | $8.89 | $1.11M | 16,763,043 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-15 | 2026-06-16 | 15,414 | $8.99 | $138.6K | 16,638,150 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-12 | 2026-06-16 | 391,019 | $8.57 | $3.35M | 16,622,736 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 1,666,829 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 160,562 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 9,445,363 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 642,250 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-11 | 2026-06-11 | 548,580 | $7.91 | $4.34M | 16,231,717 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-15 | 6,556,740 | — | $0 | 6,556,740 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-15 | 1,187,881 | — | $0 | 1,187,881 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-15 | 1,460,397 | $20.00 | $29.21M | 2,648,278 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-15 | 19,728,353 | $20.00 | $394.57M | 26,285,093 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-10 | 2026-06-11 | 103 | $7.00 | $721 | 15,683,137 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 20,215 | — | $0 | 20,215 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-09 | 2026-06-11 | 479,039 | $6.91 | $3.31M | 15,683,034 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy deriv | 2026-05-11 | 2026-05-13 | 2,170,138 | $11.52 | $25.00M | 2,170,138 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-05-11 | 2026-05-13 | 6,510,416 | $11.52 | $75.00M | 15,203,995 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-04-29 | 2026-04-29 | 2,106,000 | $9.50 | $20.01M | 22,546,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2026-03-30 | 2026-03-31 | 58,300 | $24.16 | $1.41M | 5,825,521 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2026-03-27 | 2026-03-31 | 310,700 | $23.67 | $7.35M | 5,767,221 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy deriv | 2026-02-26 | 2026-03-02 | 2,200,000 | $16.00 | $35.20M | 2,200,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2026-02-26 | 2026-03-02 | 300,000 | $16.00 | $4.80M | 4,603,418 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| EVMN Evommune, Inc. | A Award | 2026-02-17 | 2026-02-17 | 35,868 | $27.88 | $1000.0K | 2,710,293 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 222,591 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,150,941 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 767,294 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,150,941 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 272,056 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 767,294 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 2,524,473 | — | $0 | 2,524,473 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,806,644 | — | $0 | 1,806,644 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 3,441,966 | $16.00 | $55.07M | 5,966,439 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 248,034 | $16.00 | $3.97M | 2,054,678 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | A Award deriv | 2026-02-05 | 2026-02-09 | 27,400 | — | $0 | 27,400 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2026-01-05 | 2026-01-07 | 7,111 | $3.50 | $24.9K | 3,403,429 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-12 | 2025-12-15 | 101,462 | $2.86 | $290.2K | 3,396,318 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 20,440,000 | SEC↗ |
| CLYM Climb Bio, Inc. | D To issuer | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 3,081,757 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-11 | 2025-12-15 | 213,099 | $2.18 | $464.6K | 3,294,856 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 6,440 | $39.50 | $254.4K | 2,198,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 9,924 | $39.50 | $392.0K | 650,307 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 1,210 | $39.50 | $47.8K | 6,897,623 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 7,609 | $39.50 | $300.6K | 159,033 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 788 | $40.50 | $31.9K | 660,231 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 604 | $40.50 | $24.5K | 166,642 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 512 | $40.50 | $20.7K | 2,204,522 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 96 | $40.50 | $3.9K | 6,898,833 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 947 | $39.89 | $37.8K | 167,246 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 801 | $39.89 | $32.0K | 2,205,034 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 1,235 | $39.89 | $49.3K | 661,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 150 | $39.89 | $6.0K | 6,898,929 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2,276 | $40.01 | $91.1K | 6,899,081 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 18,684 | $40.01 | $747.5K | 662,266 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12,126 | $40.01 | $485.2K | 2,205,843 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 14,325 | $40.01 | $573.1K | 168,202 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2 | $40.61 | $81 | 6,899,079 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12 | $40.61 | $487 | 662,254 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 8 | $40.61 | $325 | 2,205,835 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 9 | $40.61 | $365 | 168,193 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,092 | $39.57 | $82.8K | 182,527 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 332 | $39.57 | $13.1K | 6,901,357 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,728 | $39.57 | $107.9K | 680,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 1,770 | $39.57 | $70.0K | 2,217,969 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 2,182 | $40.20 | $87.7K | 6,903,443 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 17,913 | $40.20 | $720.1K | 698,075 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 11,626 | $40.20 | $467.4K | 2,229,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,734 | $40.20 | $552.1K | 195,657 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 1,701 | $41.05 | $69.8K | 6,901,742 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,964 | $41.05 | $573.2K | 684,111 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 9,063 | $41.05 | $372.0K | 2,220,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 10,707 | $41.05 | $439.5K | 184,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 331 | $42.10 | $13.9K | 184,619 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 280 | $42.10 | $11.8K | 2,219,739 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 433 | $42.10 | $18.2K | 683,678 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 53 | $42.10 | $2.2K | 6,901,689 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 31,392 | $39.58 | $1.24M | 715,988 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 17,118 | $39.58 | $677.5K | 2,240,708 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 10,476 | $39.58 | $414.6K | 209,391 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 3,624 | $39.58 | $143.4K | 6,905,625 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 14,116 | $39.50 | $557.6K | 6,909,249 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 107,941 | $39.50 | $4.26M | 219,867 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 122,271 | $39.50 | $4.83M | 747,380 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 66,672 | $39.50 | $2.63M | 2,257,826 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-09-04 | 2025-09-08 | 1,176,470 | $25.50 | $30.00M | 5,456,521 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2025-06-24 | 2025-06-26 | 13,750 | — | $0 | 13,750 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2025-06-17 | 2025-06-20 | 16,623 | — | $0 | 16,623 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-03-13 | 2025-03-17 | 1,296,296 | $13.50 | $17.50M | 4,280,051 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,155,469 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 4,364,874 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 124,908 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 923,773 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,091,219 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 451,580 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,229,830 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 819,153 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 319,069 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 138,054 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 102,414 | $18.00 | $1.84M | 2,324,498 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 1,022,586 | $18.00 | $18.41M | 6,923,365 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 179,975 | — | $0 | 327,808 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 2,222,084 | — | $0 | 2,222,084 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 5,021,990 | — | $0 | 5,900,779 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 527,444 | — | $0 | 869,651 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion deriv | 2024-10-28 | 2024-10-30 | 14,598,896 | — | $0 | 0 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion deriv | 2024-10-28 | 2024-10-30 | 9,732,596 | — | $0 | 0 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2024-10-28 | 2024-10-30 | 341,600 | $18.00 | $6.15M | 1,471,943 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2024-10-28 | 2024-10-30 | 3,828,400 | $18.00 | $68.91M | 5,523,915 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion | 2024-10-28 | 2024-10-30 | 1,130,343 | — | $0 | 1,130,343 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion | 2024-10-28 | 2024-10-30 | 1,695,515 | — | $0 | 1,695,515 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 10,836,474 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 5,835,024 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 12,273,169 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-16 | 2024-09-18 | 18,409,755 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 2,622,898 | — | $0 | 2,622,898 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-16 | 2024-09-18 | 152,480 | $18.00 | $2.74M | 2,652,575 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-16 | 2024-09-18 | 1,680,520 | $18.00 | $30.25M | 4,303,418 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-16 | 2024-09-18 | 2,500,095 | — | $0 | 2,500,095 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 68,320 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 210,898 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 53,673 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 161,019 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 564,372 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 323,181 | $10.20 | $3.30M | 1,048,572 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 725,391 | — | $0 | 725,391 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 264,571 | — | $0 | 264,571 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 688,326 | $12.00 | $8.26M | 826,832 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 7,645,007 | $12.00 | $91.74M | 8,693,579 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 138,506 | $10.20 | $1.41M | 138,506 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 68,320 | — | $0 | 68,320 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2024-06-27 | 2024-07-01 | 1,059,375 | $3.84 | $4.07M | 2,866,375 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | P Buy | 2024-06-27 | 2024-07-01 | 11,949,171 | $3.84 | $45.88M | 23,521,757 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 973,000 | — | $0 | 11,572,586 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 1,807,000 | — | $0 | 1,807,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-07-01 | 2,479,872 | — | $0 | 2,479,872 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-28 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-02-12 | 2024-02-14 | 549,755 | $13.50 | $7.42M | 549,755 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2024-02-12 | 2024-02-14 | 1,672,508 | $13.50 | $22.58M | 2,983,755 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 1,735,629 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 192,847 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 1,118,400 | $16.00 | $17.89M | 1,311,247 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 192,847 | — | $0 | 192,847 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 1,735,629 | — | $0 | 1,735,629 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 131,600 | $16.00 | $2.11M | 1,867,229 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 44,000 | — | $0 | 44,000 | SEC↗ |